254 related articles for article (PubMed ID: 9844045)
1. Autoimmune responses to the beta cell autoantigen, insulin, and the INS VNTR-IDDM2 locus.
Sarugeri E; Dozio N; Belloni C; Meschi F; Pastore MR; Bonifacio E
Clin Exp Immunol; 1998 Dec; 114(3):370-6. PubMed ID: 9844045
[TBL] [Abstract][Full Text] [Related]
2. No association of INS-VNTR genotype and IAA autoantibodies.
Pérez de Nanclares G; Bilbao JR; Castano L
Ann N Y Acad Sci; 2004 Dec; 1037():127-30. PubMed ID: 15699505
[TBL] [Abstract][Full Text] [Related]
3. IDDM2/insulin VNTR modifies risk conferred by IDDM1/HLA for development of Type 1 diabetes and associated autoimmunity.
Walter M; Albert E; Conrad M; Keller E; Hummel M; Ferber K; Barratt BJ; Todd JA; Ziegler AG; Bonifacio E
Diabetologia; 2003 May; 46(5):712-20. PubMed ID: 12750767
[TBL] [Abstract][Full Text] [Related]
4. The insulin gene is transcribed in the human thymus and transcription levels correlated with allelic variation at the INS VNTR-IDDM2 susceptibility locus for type 1 diabetes.
Pugliese A; Zeller M; Fernandez A; Zalcberg LJ; Bartlett RJ; Ricordi C; Pietropaolo M; Eisenbarth GS; Bennett ST; Patel DD
Nat Genet; 1997 Mar; 15(3):293-7. PubMed ID: 9054945
[TBL] [Abstract][Full Text] [Related]
5. Insulin expression in human thymus is modulated by INS VNTR alleles at the IDDM2 locus.
Vafiadis P; Bennett ST; Todd JA; Nadeau J; Grabs R; Goodyer CG; Wickramasinghe S; Colle E; Polychronakos C
Nat Genet; 1997 Mar; 15(3):289-92. PubMed ID: 9054944
[TBL] [Abstract][Full Text] [Related]
6. Insulin VNTR I/III genotype is associated with autoantibodies against glutamic acid decarboxylase in newly diagnosed type 1 diabetes.
Rajasalu T; Haller K; Salur L; Kisand K; Tillmann V; Schlosser M; Uibo R
Diabetes Metab Res Rev; 2007 Oct; 23(7):567-71. PubMed ID: 17461431
[TBL] [Abstract][Full Text] [Related]
7. Imprinted and genotype-specific expression of genes at the IDDM2 locus in pancreas and leucocytes.
Vafiadis P; Bennett ST; Colle E; Grabs R; Goodyer CG; Polychronakos C
J Autoimmun; 1996 Jun; 9(3):397-403. PubMed ID: 8816977
[TBL] [Abstract][Full Text] [Related]
8. HLA DRB1, DQB1 and insulin promoter VNTR polymorphisms: interactions and the association with adult-onset diabetes mellitus in Czech patients.
Cejkova P; Novota P; Cerna M; Kolostova K; Novakova D; Kucera P; Novak J; Andel M; Weber P; Zdarsky E
Int J Immunogenet; 2008 Apr; 35(2):133-40. PubMed ID: 18279373
[TBL] [Abstract][Full Text] [Related]
9. Divergence between genetic determinants of IGF2 transcription levels in leukocytes and of IDDM2-encoded susceptibility to type 1 diabetes.
Vafiadis P; Bennett ST; Todd JA; Grabs R; Polychronakos C
J Clin Endocrinol Metab; 1998 Aug; 83(8):2933-9. PubMed ID: 9709972
[TBL] [Abstract][Full Text] [Related]
10. Evidence for a Type 1 diabetes-specific mechanism for the insulin gene-associated IDDM2 locus rather than a general influence on autoimmunity.
Tait KF; Collins JE; Heward JM; Eaves I; Snook H; Franklyn JA; Barnett AH; Todd JA; Maranian M; Compston A; Sawcer S; Gough SC
Diabet Med; 2004 Mar; 21(3):267-70. PubMed ID: 15008838
[TBL] [Abstract][Full Text] [Related]
11. IDDM2-VNTR-encoded susceptibility to type 1 diabetes: dominant protection and parental transmission of alleles of the insulin gene-linked minisatellite locus.
Bennett ST; Wilson AJ; Cucca F; Nerup J; Pociot F; McKinney PA; Barnett AH; Bain SC; Todd JA
J Autoimmun; 1996 Jun; 9(3):415-21. PubMed ID: 8816980
[TBL] [Abstract][Full Text] [Related]
12. Insulin gene/IDDM2 locus in Japanese type 1 diabetes: contribution of class I alleles and influence of class I subdivision in susceptibility to type 1 diabetes.
Awata T; Kawasaki E; Ikegami H; Kobayashi T; Maruyama T; Nakanishi K; Shimada A; Iizuka H; Kurihara S; Osaki M; Uga M; Kawabata Y; Tanaka S; Kanazawa Y; Katayama S
J Clin Endocrinol Metab; 2007 May; 92(5):1791-5. PubMed ID: 17341563
[TBL] [Abstract][Full Text] [Related]
13. CTLA-4 gene polymorphism confers susceptibility to insulin-dependent diabetes mellitus (IDDM) independently from age and from other genetic or immune disease markers. The Belgian Diabetes Registry.
Van der Auwera BJ; Vandewalle CL; Schuit FC; Winnock F; De Leeuw IH; Van Imschoot S; Lamberigts G; Gorus FK
Clin Exp Immunol; 1997 Oct; 110(1):98-103. PubMed ID: 9353155
[TBL] [Abstract][Full Text] [Related]
14. The effect of HLA class II, insulin and CTLA4 gene regions on the development of humoral beta cell autoimmunity.
Hermann R; Laine AP; Veijola R; Vahlberg T; Simell S; Lähde J; Simell O; Knip M; Ilonen J
Diabetologia; 2005 Sep; 48(9):1766-75. PubMed ID: 16025255
[TBL] [Abstract][Full Text] [Related]
15. Diabetes susceptibility at IDDM2 cannot be positively mapped to the VNTR locus of the insulin gene.
Doria A; Lee J; Warram JH; Krolewski AS
Diabetologia; 1996 May; 39(5):594-9. PubMed ID: 8739920
[TBL] [Abstract][Full Text] [Related]
16. A genetic explanation for the rising incidence of type 1 diabetes, a polygenic disease.
Awdeh ZL; Yunis EJ; Audeh MJ; Fici D; Pugliese A; Larsen CE; Alper CA
J Autoimmun; 2006 Nov; 27(3):174-81. PubMed ID: 17052889
[TBL] [Abstract][Full Text] [Related]
17. Impact of IDDM2 on disease pathogenesis and progression in children with newly diagnosed type 1 diabetes: reduced insulin antibody titres and preserved beta cell function.
Nielsen LB; Mortensen HB; Chiarelli F; Holl R; Swift P; de Beaufort C; Pociot F; Hougaard P; Gammeltoft S; Knip M; Hansen L;
Diabetologia; 2006 Jan; 49(1):71-4. PubMed ID: 16307231
[TBL] [Abstract][Full Text] [Related]
18. A functional analysis of the role of IGF2 in IDDM2-encoded susceptibility to type 1 diabetes.
Vafiadis P; Grabs R; Goodyer CG; Colle E; Polychronakos C
Diabetes; 1998 May; 47(5):831-6. PubMed ID: 9588457
[TBL] [Abstract][Full Text] [Related]
19. Associations of polymorphisms in non-HLA loci with autoantibodies at the diagnosis of type 1 diabetes: INS and IKZF4 associate with insulin autoantibodies.
Lempainen J; Härkönen T; Laine A; Knip M; Ilonen J;
Pediatr Diabetes; 2013 Nov; 14(7):490-6. PubMed ID: 23721563
[TBL] [Abstract][Full Text] [Related]
20. Dendritic Cells Guide Islet Autoimmunity through a Restricted and Uniquely Processed Peptidome Presented by High-Risk HLA-DR.
van Lummel M; van Veelen PA; de Ru AH; Janssen GM; Pool J; Laban S; Joosten AM; Nikolic T; Drijfhout JW; Mearin ML; Aanstoot HJ; Peakman M; Roep BO
J Immunol; 2016 Apr; 196(8):3253-63. PubMed ID: 26944932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
